The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 3 randomized, placebo-controlled double-blind study of ARN-509 plus abiraterone acetate (AA) in chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC).
 
Dana E. Rathkopf
Consulting or Advisory Role - Janssen Oncology
Research Funding - Celgene (Inst); Janssen Oncology (Inst); Medivation (Inst); Takeda (Inst)
 
Gerhardt Attard
Employment - Institute of Cancer Research
Honoraria - Astellas Pharma; Janssen; Sanofi; Takeda; Ventana Medical Systems
Consulting or Advisory Role - Abbott Laboratories; Astellas Pharma; Janssen-Cilag; Medivation; Millennium; Novartis; Ventana Medical Systems; Veridex
Research Funding - AstraZeneca; Janssen
Other Relationship - Abbott Laboratories; Astellas Pharma; Janssen; Medivation; Ventana Medical Systems
 
Eleni Efstathiou
Honoraria - Johnson & Johnson; Millennium; Sanofi
Consulting or Advisory Role - Johnson & Johnson; Millennium; Sanofi
Research Funding - Johnson & Johnson; Medivation; Millennium; Sanofi; Viamet Pharmaceuticals
 
Margaret K. Yu
Employment - Janssen
Stock and Other Ownership Interests - Johnson & Johnson
 
Thomas W. Griffin
Employment - Janssen Oncology
Stock and Other Ownership Interests - Janssen Oncology
 
Mary Beth Todd
Employment - Janssen
Stock and Other Ownership Interests - Johnson & Johnson
 
Daphne Wu
Employment - Janssen
Stock and Other Ownership Interests - Johnson & Johnson
 
Thian Kheoh
Employment - Janssen Research & Development
Leadership - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Xin Zhao
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Fred Saad
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Janssen Oncology; Novartis; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; Bavarian Nordic; Janssen Oncology; Millennium; Novartis; Sanofi
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Oncogenex (Inst); Sanofi (Inst)